ASXL1 and myelodysplastic syndrome: In this context, U2AF1 mutations and ASXL1 alterations are present in approximately half of MDS patients with isolated del(20q) and detection at diagnosis would help to identify different subgroups with worse prognosis that could benefit from earlier treatment.